JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?
about
The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathwayA phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cellsOpposite effect of NF-kB and c-Jun N-terminal kinase on p53-independent GADD45 induction by arseniteVanadate induction of NF-kB involves IkB kinase B and SAPK/ERK kinasa 1 in macrophagesMixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complexContrasting roles of NF-kB and JNK in arsenite-induced p53-independent expression of GADD45alphaSignaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domainControl of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alphaIdentification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signalingRegulation of IkappaBalpha expression involves both NF-kappaB and the MAP kinase signaling pathways.Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motifMitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-betaNF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylationNAK is an IkappaB kinase-activating kinaseMediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1)Cellular and molecular effects of resveratrol in health and diseaseHydrogen peroxide-mediated inhibition of lipopolysaccharide-stimulated inhibitory kappa B kinase activity in rat aortic smooth muscle cellsN-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) suppresses microglial inducible nitric oxide synthase (iNOS) expression and activity induced by interferon-gamma (IFN-gamma)The inhibition of NF-kappaB activation pathways and the induction of apoptosis by dithiocarbamates in T cells are blocked by the glutathione precursor N-acetyl-L-cysteineNF-kappaB and not the MAPK signaling pathway regulates GADD45beta expression during acute inflammation.Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex.Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway.Persistent activation of NF-kappaB by the tax transforming protein of HTLV-1: hijacking cellular IkappaB kinases.Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.Gamma interferon and lipopolysaccharide interact at the level of transcription to induce tumor necrosis factor alpha expression.NF-kappaB signaling proteins as therapeutic targets for inflammatory bowel diseases.Pathogen-induced apoptosis of macrophages: a common end for different pathogenic strategies.The I kappa B kinase: a master regulator of NF-kappa B, innate immunity, and epidermal differentiation.Activation of the immune system by bacterial CpG-DNA.Nepalolide A inhibits the expression of inducible nitric oxide synthase by modulating the degradation of IkappaB-alpha and IkappaB-beta in C6 glioma cells and rat primary astrocytes.MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation.Negative feedback loop in T-cell activation through MAPK-catalyzed threonine phosphorylation of LAT.The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis.Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway.Low levels of arsenite activates nuclear factor-kappaB and activator protein-1 in immortalized mesencephalic cells.Identification of human metapneumovirus-induced gene networks in airway epithelial cells by microarray analysis.
P2860
Q22009096-E3C5DBF2-DAA2-43CC-99C8-212368DC7EA4Q22253428-82EBCC7E-0E7F-4052-B63D-02DD10002894Q23912784-FE4DE511-A8E1-4229-8FA2-C42A291A8546Q23912830-D903D9E4-B3F0-4463-A7B6-AD68166E33B7Q24554281-22450188-FD2D-462A-8AB2-9B46002D55CCQ24584676-1C42836E-DE17-4854-A769-AA08AF8F2DA4Q24604330-48909D79-A7E6-4921-8B57-4DEA504B92E6Q24676497-37F48085-B056-472C-81E0-BBB0194E73DCQ24679268-9A6489C3-5382-4F28-A555-A9F6D95F45A6Q24815441-147519B8-2692-4AEE-B78C-1373AAA6AB53Q28138697-8D445D9E-BB2A-4FD2-A474-07CE55ADE405Q28139163-5DF669B3-512A-481A-9981-2F0DB75FBE2DQ28141521-B81AE15C-9B24-4916-A87B-77C9F81F0265Q28143033-D16A648C-F00B-499B-9E53-B8E54BBBCF58Q28145951-3FAD5F71-D310-43EC-A7C2-0296DFAFB790Q28252560-A76F325F-B087-4FD9-B594-D1A120890CB9Q28359294-4ACFB407-DC00-44F8-9E12-C49307C74396Q28363765-4713A15B-7084-4FCE-95B8-D44B751EBCE4Q28369779-3C6B5039-0752-4A0E-8FFD-74485E884783Q31157266-729FCCFF-24AD-42DD-AED6-EA9780915DA6Q33663188-F5D45467-0C36-46E1-AD10-B8B072614D69Q33782305-DF932DD9-FC5D-4430-A67B-832FC6BA4AEAQ33797139-B8726572-C38A-4486-B7A2-0869C34407B3Q33797156-36DDD68A-ECB3-4921-AA75-6B741E82B8E8Q33797174-FEC56C21-0F8F-4513-9739-F112684D4414Q33815241-89AB25F6-483A-453E-8C84-20B085BD8395Q33863064-046AC103-174D-44C3-AE8E-F2E6E6DD2D21Q34007141-EC89DEAC-4D52-4CC8-BA14-1B1CB054C802Q34015898-3556757E-1532-4E57-9EF1-9D3E7D4726BEQ34156265-180B307B-A38B-452B-A7E6-9C589E49E706Q34170916-988FD640-B40C-4343-9397-15A04BEC58BCQ34579763-7DB75C26-46FC-4563-836A-A987AE46FFD6Q35041515-E83E94CC-8CB1-42B8-98EB-DA25A7A09390Q35156450-D1A75FFB-A089-47EB-8BAD-9DA04EC02336Q35836197-D7CC226C-0D8F-4549-860C-7F5F2EE9B86EQ36368249-0433BCAA-0F4E-43FF-A992-E183C1435B5DQ36369124-666EF6D6-041D-4AB6-8833-B6ABEB05FD24Q37338884-AF47218E-CD6B-4B06-B5E5-DC9B5A098E5BQ37346650-83787354-D01F-4300-9E57-1AF8021A8687Q37421827-82E58F8B-E04F-498B-9176-4B9A7465A788
P2860
JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?
@ast
JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?
@en
type
label
JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?
@ast
JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?
@en
prefLabel
JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?
@ast
JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?
@en
P2860
P356
P1476
JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?
@en
P2093
P2860
P304
P356
10.1073/PNAS.95.16.9067
P407
P577
1998-08-01T00:00:00Z